LENZ Therapeutics, Inc.LENZNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank60
Studio
Year-over-Year Change

Free cash flow yield

Latest
-9.74%
↑ 63% vs avg
Percentile
P60
Within normal range
Streak
2 yr
Consecutive growthElevated
Average
-26.63%
Historical baseline
PeriodValueYoY Change
2024-9.74%+83.7%
2023-59.81%+22.1%
2022-76.79%-539.0%
2021-12.02%-750.5%
2020-1.41%-53931.6%
2019-0.00%-